Archive for May 15th, 2012

OSUR positive Adcom vote. SNSS interim data due 3Q. CYTR reverse split.

May 15, 2012 No Comments by

Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) said today that it is on track to release interim data from its Phase 3 VALOR trial in acute myeloid leukemia, during 3Q 2012. CytRx Corporation (Nasdaq: CYTR) today announced a reverse split of its common stock at a ratio of 1-for-7. CytRx’s common stock will begin trading on NASDAQ on a split-adjusted […]

Daily News Read more